A pan-cancer expression analysis revealed the association of selenoprotein P (SELENOP) with a better prognosis in most cancers, but a poorer prognosis in brain glioma and uterine corpus endometrioid carcinoma [51]. This evidence concerns the gene SELENOP and endometrial endometrioid adenocarcinoma.